Table 2

Comparison between AF recurrence and recurrence-free groups a

Groups Application number ( n ) LA size (mm) bLA volume (ml) LA surface area (cm 2 ) Perimeter of silent region (cm) Silent area (cm 2 ) % of silent area of LA surfacePre-ablation voltage map in the LA (mV)
Appendage PV ostia cPIAOther parts
Total79 ± 2143 ± 5116 ± 39168 ± 4027 ± 451 ± 1131 ± 42.25 ± 0.830.51 ± 0.341.28 ± 0.671.35 ± 0.59
Recurrence-free79 ± 2242 ± 5107 ± 28164 ± 3427 ± 351 ± 1032 ± 42.41 ± 0.750.60 ± 0.351.42 ± 0.661.47 ± 0.57
Recurrence80 ± 1847 ± 5149 ± 53184 ± 5728 ± 650 ± 1527 ± 31.72 ± 0.900.25 ± 0.120.81 ± 0.490.92 ± 0.48
P -value 0.940.020.0020.190.700.910.0010.030.040.020.01
Groups Application number ( n ) LA size (mm) bLA volume (ml) LA surface area (cm 2 ) Perimeter of silent region (cm) Silent area (cm 2 ) % of silent area of LA surfacePre-ablation voltage map in the LA (mV)
Appendage PV ostia cPIAOther parts
Total79 ± 2143 ± 5116 ± 39168 ± 4027 ± 451 ± 1131 ± 42.25 ± 0.830.51 ± 0.341.28 ± 0.671.35 ± 0.59
Recurrence-free79 ± 2242 ± 5107 ± 28164 ± 3427 ± 351 ± 1032 ± 42.41 ± 0.750.60 ± 0.351.42 ± 0.661.47 ± 0.57
Recurrence80 ± 1847 ± 5149 ± 53184 ± 5728 ± 650 ± 1527 ± 31.72 ± 0.900.25 ± 0.120.81 ± 0.490.92 ± 0.48
P -value 0.940.020.0020.190.700.910.0010.030.040.020.01

AF, atrial fibrillation; PIA, posterior inter-pulmonary-vein atrium; PV, pulmonary vein; LA, left atrium; an = 40, data from two patients are not available due to unsuccessful electrical cardioversion. b Measured in the left parasternal long axis view. cn = 20, 20 patients (16 in recurrence-free and 4 in recurrence group) who underwent earlier PV isolation were excluded from the analysis.

Table 2

Comparison between AF recurrence and recurrence-free groups a

Groups Application number ( n ) LA size (mm) bLA volume (ml) LA surface area (cm 2 ) Perimeter of silent region (cm) Silent area (cm 2 ) % of silent area of LA surfacePre-ablation voltage map in the LA (mV)
Appendage PV ostia cPIAOther parts
Total79 ± 2143 ± 5116 ± 39168 ± 4027 ± 451 ± 1131 ± 42.25 ± 0.830.51 ± 0.341.28 ± 0.671.35 ± 0.59
Recurrence-free79 ± 2242 ± 5107 ± 28164 ± 3427 ± 351 ± 1032 ± 42.41 ± 0.750.60 ± 0.351.42 ± 0.661.47 ± 0.57
Recurrence80 ± 1847 ± 5149 ± 53184 ± 5728 ± 650 ± 1527 ± 31.72 ± 0.900.25 ± 0.120.81 ± 0.490.92 ± 0.48
P -value 0.940.020.0020.190.700.910.0010.030.040.020.01
Groups Application number ( n ) LA size (mm) bLA volume (ml) LA surface area (cm 2 ) Perimeter of silent region (cm) Silent area (cm 2 ) % of silent area of LA surfacePre-ablation voltage map in the LA (mV)
Appendage PV ostia cPIAOther parts
Total79 ± 2143 ± 5116 ± 39168 ± 4027 ± 451 ± 1131 ± 42.25 ± 0.830.51 ± 0.341.28 ± 0.671.35 ± 0.59
Recurrence-free79 ± 2242 ± 5107 ± 28164 ± 3427 ± 351 ± 1032 ± 42.41 ± 0.750.60 ± 0.351.42 ± 0.661.47 ± 0.57
Recurrence80 ± 1847 ± 5149 ± 53184 ± 5728 ± 650 ± 1527 ± 31.72 ± 0.900.25 ± 0.120.81 ± 0.490.92 ± 0.48
P -value 0.940.020.0020.190.700.910.0010.030.040.020.01

AF, atrial fibrillation; PIA, posterior inter-pulmonary-vein atrium; PV, pulmonary vein; LA, left atrium; an = 40, data from two patients are not available due to unsuccessful electrical cardioversion. b Measured in the left parasternal long axis view. cn = 20, 20 patients (16 in recurrence-free and 4 in recurrence group) who underwent earlier PV isolation were excluded from the analysis.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close